中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

2020 Vol. 36, No. 11

Display Method:
Editorial
Emphasis on the basic and clinical research on hepatorenal syndrome
LI Yan, LU LunGen
2020, 36(11): 2401-2405. DOI: 10.3969/j.issn.1001-5256.2020.11.001
Abstract(5054) PDF (245KB)(221)
Abstract:

Hepatorenal syndrome( HRS) is one of the most severe complications of decompensated cirrhosis. Splanchnic arterial vasodilation in patients with advanced liver cirrhosis and the reduction in cardiac output due to cirrhotic cardiomyopathy may trigger the reduction in effective circulating blood volum...

Discussions by experts
Pathogenesis of hepatorenal syndrome
LIAO XianHua, YE JunZhao, ZHONG BiHui
2020, 36(11): 2406-2410. DOI: 10.3969/j.issn.1001-5256.2020.11.002
Abstract(5524) PDF (242KB)(296)
Abstract:

Hepatorenal syndrome( HRS) is one of the common serious complications in patients with end-stage liver disease and has poor prognosis and high mortality,and in-depth studies on its pathogenesis will help to achieve precise prevention and treatment. Although the exact pathogenesis of HRS has not yet ...

Risk factors,diagnosis,and updated classification of hepatorenal syndrome
LI ZhengHong, DONG YuWei, LU LunGen
2020, 36(11): 2411-2414. DOI: 10.3969/j.issn.1001-5256.2020.11.003
Abstract(5857) PDF (220KB)(268)
Abstract:

Hepatorenal syndrome( HRS) is a common complication of decompensated cirrhosis and is traditionally defined as progressive oliguria or anuria,azotemia,dilutional hyponatremia,and hyponatremia,while renal insufficiency without marked organic lesions in the kidney is the typical manifestation of HRS. ...

Advances in the treatment of hepatorenal syndrome
LI Yan, LU LunGen, CAI XiaoBo
2020, 36(11): 2415-2418. DOI: 10.3969/j.issn.1001-5256.2020.11.004
Abstract(5622) PDF (213KB)(313)
Abstract:

Hepatorenal syndrome is one of the major complications of decompensated cirrhosis secondary to the reduction in effective blood volume,imbalance of endogenous vasoactive substances,and the reduction in renal blood flow,with renal insufficiency as the main manifestation. In clinical practice,hepatore...

Treatment of hepatorenal syndrome:Vasoconstriction or vasodilation?
LI XiaoYun, HUA Jing
2020, 36(11): 2419-2422. DOI: 10.3969/j.issn.1001-5256.2020.11.005
Abstract:

Hepatorenal syndrome( HRS) is a serious complication that occurs in patients with decompensated cirrhosis or acute/chronic liver failure. The main pathological features of HRS include marked peripheral vasodilation and strong renal vasoconstriction,with rapid progression,unsatisfactory treatment res...

Acute kidney injury and hepatorenal syndrome in end-stage liver disease
CHEN WenJi, LIANG Wei, ZHOU YongJian
2020, 36(11): 2423-2428. DOI: 10.3969/j.issn.1001-5256.2020.11.006
Abstract(5031) PDF (462KB)(218)
Abstract:

Acute kidney injury( AKI) and hepatorenal syndrome( HRS) are serious complications in patients with end-stage liver disease,with renal injury as the main manifestation. They are interrelated,but also different from each other. There are several types of AKI,i. e.,prerenal AKI,intrarenal or intrinsic...

Guidelines
Chinese expert consensus on application of sirolimus in liver transplantation for hepatocellular carcinoma(2020 edition)
Committee of Liver Transplantation, Chinese College of Transplant Doctors, Chinese Medical Doctor Association, Section of Liver Transplantation, Chinese Society of Organ Transplantation, Chinese Medical Association
2020, 36(11): 2429-2434. DOI: 10.3969/j.issn.1001-5256.2020.11.007
Abstract:
Original articles_Viral hepatitis
Change and significance of HBcAg-specific Th22 cells in patients with hepatitis B virus infection
JIN Juan, HUANG XiaoZheng, JING XinYan, ZHANG Yuan, YIN JinLing, LI JiaJia, WANG SiSi, GUO YaLing, LI Ying
2020, 36(11): 2435-2440. DOI: 10.3969/j.issn.1001-5256.2020.11.008
Abstract:

Objective To investigate the changes of Th22 cells,interleukin-22( IL-22),and transcription factor aryl hydrocarbon receptor( AhR) in patients with hepatitis B virus( HBV) infection and their correlation with clinical indices. Methods A total of 11 patients with acute hepatitis B( AHB) and 38 patien...

Association of interleukin-2 receptor expression with liver pathological changes in patients with chronic hepatitis B
WANG Tao, JIANG YuanYe, WANG XueWei, GAO JingJing, CAO Qin
2020, 36(11): 2441-2445. DOI: 10.3969/j.issn.1001-5256.2020.11.009
Abstract:

Objective To investigate the association between serum interleukin( IL) and liver pathological changes in patients with chronic hepatitis B( CHB). Methods A total of 59 patients with CHB who were treated in Putuo District Central Hospital of Shanghai from February 2018 to February 2019 were enrolled...

Original articles_Liver fibrosis and liver cirrhosis
Value of highly sensitive nucleic acid detection and aminotransferase level in evaluating precise antiviral therapy for liver cirrhosis patients with a low viral load
LIN Yan, ZHANG YueRong, WANG Hui, ZHANG YaoDi, WU LiYang, WEI ShiFang, LI XiangLin, MA YanYun, WANG ChunXia
2020, 36(11): 2446-2449. DOI: 10.3969/j.issn.1001-5256.2020.11.010
Abstract(4851) PDF (351KB)(122)
Abstract:

Objective To investigate the clinical significance of highly sensitive nucleic acid detection in precise antiviral therapy for patients with liver cirrhosis and its association with aminotransferase level. Methods A total of 377 patients with hepatitis B cirrhosis who were hospitalized or attended t...

Original articles_Liver neoplasms
Expression and significance of programmed death-1 and T-cell immunoglobulin-and mucin domain-3-containing molecule 3 in hepatocellular carcinoma
ZHOU Ge, XIE LiPing, LIN TaoFa, LU YouGuang, WANG ShaoYang
2020, 36(11): 2450-2455. DOI: 10.3969/j.issn.1001-5256.2020.11.011
Abstract:

Objective To investigate the expression and clinical significance of programmed death-1(PD-1) and T-cell immunoglobulin-and mucin domain-3-containing molecule 3(TIM-3) in hepatocellular carcinoma(HCC).Methods The paraffin blocks of HCC tissue and adjacent tissue(> 1 cm from the tumor margin) were...

Original articles_Other liver diseases
Expression and clinical significance of the NK cell-activating receptor NKG2D and its ligand in liver tissue of patients with primary biliary cholangitis
YU HaiYan, WEI JinXiang, FU HaiYan, YANG YiNa, TU RongFang, TANG YingMei
2020, 36(11): 2456-2461. DOI: 10.3969/j.issn.1001-5256.2020.11.012
Abstract:

Objective To investigate the association of the expression of the NK cell-activating receptor NKG2 D,its ligand major histocompatibility complex class I chain-related gene A( MICA),and related cytokines [interferon-γ( IFN-γ),interleukin-10( IL-10),and interleukin-15( IL-15) ] with intrahepatic infla...

Value of Model for End-Stage Liver Disease and Child-Turcotte-Pugh score in predicting the prognosis of patients with hepatic sinus obstruction syndrome associated with Gynura segetum( Lour. ) Merr.
LIU ZhenLi, FAN ZuoPeng, LIU YaLi, ZHANG Jing
2020, 36(11): 2462-2466. DOI: 10.3969/j.issn.1001-5256.2020.11.013
Abstract:

Objective To investigate the value of Model for End-Stage Liver Disease( MELD) and Child-Turcotte-Pugh( CTP) score in predicting the prognosis of patients with hepatic sinusoidal obstruction syndrome( HSOS) associated with Gynura segetum( Lour.) Merr.Methods A total of 49 patients with HSOS associat...

Implementation of aerobic exercise intervention in patients with metabolic associated fatty liver disease:A prospective study
LIU YingYing, LIU YuPing, LIU YouRen, SUN Ping
2020, 36(11): 2467-2472. DOI: 10.3969/j.issn.1001-5256.2020.11.014
Abstract(4646) PDF (298KB)(112)
Abstract:

Objective To investigate the intervention effect of moderate-intensity aerobic exercise on patients with metabolic associated fatty liver disease( MAFLD) and preliminary intervention regimens,and to provide a theoretical basis and new ideas for the effective prevention and treatment of MAFLD. Method...

Association of liver stiffness measurement and serum biochemical parameters with nonalcoholic steatohepatitis
FU YiMing, JI Dong, SHAO Qing, LI ZhongBin, WANG ChunYan, CHEN SongHai, CHEN GuoFeng
2020, 36(11): 2473-2477. DOI: 10.3969/j.issn.1001-5256.2020.11.015
Abstract(4808) PDF (900KB)(151)
Abstract:

Objective To investigate the association of liver stiffness measurement( LSM) and serum biochemical parameters with hepatic steatosis,liver inflammation,and liver fibrosis in patients with nonalcoholic steatohepatitis( NASH). Methods A total of 520 patients with NASH who were treated in The Fifth Me...

Expression and significance of leptin and adiponectin in serum of patients with nonalcoholic fatty liver disease and coronary heart disease
XU Zhen, LIU ShouSheng, TAN Jie, SUN BaoKai, DU ShuiXian, XIN YongNing, XUAN ShiYing
2020, 36(11): 2478-2483. DOI: 10.3969/j.issn.1001-5256.2020.11.016
Abstract:

Objective To investigate the expression of leptin( LEP) and adiponectin( ADPN) in the serum of patients with nonalcoholic fatty liver disease( NAFLD) and coronary heart disease( CHD) and the association of LEP and ADPN with NAFLD and CHD. Methods A total of 83 patients with NAFLD,86 patients with NA...

Effect of Quzhi Ruangan decoction on the mRNA and protein expression of organic anion transporting polypeptide 2B1 in the small intestine of rats with nonalcoholic fatty liver disease
ZHANG SuYan, XIA EnRui, ZHOU QingLi, ZHANG ShunZhen
2020, 36(11): 2484-2488. DOI: 10.3969/j.issn.1001-5256.2020.11.017
Abstract:

Objective To investigate the effect of Quzhi Ruangan decoction on the mRNA and protein expression of organic anion transporting polypeptide 2 B1( OATP2 B1) in the small intestine of rats with nonalcoholic fatty liver disease( NAFLD). Methods After 1 week of adaptive feeding,36 male Sprague-Dawley ra...

Original articles_Biliary diseases
Influencing factors for infection with multidrug-resistant organisms in patients with chronic calculous cholecystitis
XIE ChaoYun, ZHANG Ping, YANG Huai, MO LiXian, WANG MinKai
2020, 36(11): 2489-2493. DOI: 10.3969/j.issn.1001-5256.2020.11.018
Abstract:

Objective To investigate the influencing factors for multidrug-resistant organisms( MDRO) infection in patients with chronic calculous cholecystitis. Methods A retrospective analysis was performed for 654 patients with chronic calculous cholecystitis who underwent cholecystectomy in The Third Affili...

Efficacy and safety of endoscopic papillary large balloon dilation alone versus endoscopic sphincterotomy combined with large balloon dilation in treatment of large common bile duct stones:A Meta-analysis
LI XingZhi, WU ChangWei, REN LiKun, LIU Hao, HAN Min
2020, 36(11): 2494-2499. DOI: 10.3969/j.issn.1001-5256.2020.11.019
Abstract:

Objective To systematically review the efficacy and safety of endoscopic papillary large balloon dilation( EPLBD) versus endoscopic sphincterotomy combined with large balloon dilation( ESBD) in the treatment of large common bile duct stones( ≥10 mm). Methods Pubmed,Embase,Cochrane Library,CNKI,Wanfa...

Influence of longitudinal trajectories of body mass index on new-onset gallstone disease
TAO Ming, LIU Qing, CUI HaoZhe, LIU XiNing, WANG YiMing, LIU SiQing, CAO LiYing
2020, 36(11): 2500-2504. DOI: 10.3969/j.issn.1001-5256.2020.11.020
Abstract:

Objective To investigate the effect of longitudinal trajectories of body mass index( BMI) on new-onset gallstone disease.Methods A prospective cohort study was conducted for 44168 employees who underwent physical examination in Kailuan General Hospital in 2006,2008,and 2010,and related data,includin...

Original articles_Pancreatic diseases
Value of serum cystatin C in predicting acute kidney injury in patients with acute pancreatitis
CHEN YuQing, JIANG Xin, XU Huan, ZHONG Rui, LI PeiLing, ZHANG Lu, PENG Yan, TANG XiaoWei
2020, 36(11): 2505-2508. DOI: 10.3969/j.issn.1001-5256.2020.11.021
Abstract:

Objective To investigate the value of serum cystatin C in the early prediction of acute kidney injury( AKI) in patients with acute pancreatitis( AP). Methods A retrospective analysis was performed for the clinical data of 273 patients with AP who were admitted to The Affiliated Hospital of Southwest...

Influence of serum triglyceride level on the prognosis of acute biliary pancreatitis
JIANG Xin, YAN YongFeng, ZHONG Rui, XU Huan, PENG Yan, TANG XiaoWei
2020, 36(11): 2509-2514. DOI: 10.3969/j.issn.1001-5256.2020.11.022
Abstract(4608) PDF (539KB)(109)
Abstract:

Objective To investigate the influence of serum triglyceride( TG) level on the outcome of acute biliary pancreatitis( ABP).Methods A retrospective analysis was performed for 249 ABP patients who were admitted to The Affiliated Hospital of Southwest Medical University from September 2018 to August 20...

Influence of metabolic syndrome on patients with recurrence of hypertriglyceridemic acute pancreatitis
LI XianQiu, LIU Hui, XIAO ChunTao, LUO Gang, ZHOU Xian
2020, 36(11): 2515-2520. DOI: 10.3969/j.issn.1001-5256.2020.11.023
Abstract:

Objective To investigate the features of patients with recurrence of hypertriglyceridemic acute pancreatitis( HTG-AP) and the influence of metabolic syndrome( MetS) on recurrence through a retrospective analysis. Methods A retrospective analysis was performed for 132 patients with recurrent HTG-AP w...

Brief reports
Causes of abnormal liver function in children:An analysis of 146 cases
WANG HongYu, WU Jie
2020, 36(11): 2521-2523. DOI: 10.3969/j.issn.1001-5256.2020.11.024
Abstract:
Clinical characteristics of 12 patients with primary myelofibrosis and liver cirrhosis
WANG Xuan, HE TingTing, ZHANG Ning, ZHOU Chao, WANG Yao, BAI YunFeng, ZHANG JingJing, FU ShuangNan, LIANG XiaoXiao, LI Cuan, GONG Man
2020, 36(11): 2524-2526. DOI: 10.3969/j.issn.1001-5256.2020.11.025
Abstract:
Pregnancy with cirrhosis:A clinical analysis of 48 cases
CAO MinKai, JIANG HongXiu, DING Yi, ZHOU GuanLun, CHEN Chao, HAN GuoRong
2020, 36(11): 2527-2529. DOI: 10.3969/j.issn.1001-5256.2020.11.026
Abstract:
Clinical characteristics of liver injury induced by environmental toxins:An analysis of 8 cases
HE TingTing, ZHOU GuangDe, LIU ShuHong, ZHOU Chao, ZHU Li, ZHANG Ning, WANG Yan, XIAO XiaoHe, GONG Man
2020, 36(11): 2530-2533. DOI: 10.3969/j.issn.1001-5256.2020.11.027
Abstract:
Case reports
Pegylated interferon for treatment of chronic hepatitis B-induced thrombotic thrombocytopenic purpura:A case report
WANG XinRu, XIAO Li, GENG AiWen, XIAN JianChun
2020, 36(11): 2534-2536. DOI: 10.3969/j.issn.1001-5256.2020.11.028
Abstract:
A case of idiopathic non-cirrhotic portal hypertension with hepatic encephalopathy as the first symptom
TAO Yu, ZHI YiXiao, PANG MengYuan, SU Jie, HUA Rui
2020, 36(11): 2537-2538. DOI: 10.3969/j.issn.1001-5256.2020.11.029
Abstract:
Crigler-Najjar syndrome type Ⅱ:A case report and literature review
ZENG Jing, GE WenSong, YANG RuiXu, FAN JianGao, WANG BaoCan
2020, 36(11): 2539-2541. DOI: 10.3969/j.issn.1001-5256.2020.11.030
Abstract:
A case of liver transplantation for acute liver failure due to adult-onset Still's disease with macrophage activation syndrome
MA HaiYing, LIU Yan, LI ZhiQin, WANG Hu, ZHANG LingQiang, CHEN Hong, FAN HaiNing
2020, 36(11): 2542-2544. DOI: 10.3969/j.issn.1001-5256.2020.11.031
Abstract:
Recurrence of erythropoietic protoporphyria after liver transplantation:A case report and literature review
WANG HongBo, LI LiCuan, YU YanBin, MENG LingZhan, BAI Ying, LI XiaoDong, SUN YanLing, LIU ZhenWen
2020, 36(11): 2545-2547. DOI: 10.3969/j.issn.1001-5256.2020.11.032
Abstract:
IgG4-associated autoimmune pancreatitis with pancreatic cancer:A case report
CAO GuangHua, YU YaNan, LIU Peng, PEI JinYu, ZHAO Wei
2020, 36(11): 2548-2549. DOI: 10.3969/j.issn.1001-5256.2020.11.033
Abstract:
Primary large cell neuroendocrine carcinoma of the ampulla of Vater:A case report
ZHENG BoWen, WANG ChuanLei, LIU Huan, LV HaoZe, WEI Feng
2020, 36(11): 2550-2552. DOI: 10.3969/j.issn.1001-5256.2020.11.034
Abstract:
Reviews
Drug resistance of direct-acting antivirals in genotype 2/3 hepatitis C virus
CHEN HongYu, XU XiaoYuan
2020, 36(11): 2553-2556. DOI: 10.3969/j.issn.1001-5256.2020.11.035
Abstract:

Since the development of direct-acting antivirals( DAAs) for hepatitis C virus( HCV),more than 95% of the patients with hepatitis C can be cured,but a very small proportion of patients still face treatment failure. There are many reasons for treatment failure,among which HCV genotype and resistance-...

Research advances in proton pump inhibitor and complications of liver cirrhosis
LIU LinXiang, NIE Yuan, ZHU Xuan
2020, 36(11): 2557-2560. DOI: 10.3969/j.issn.1001-5256.2020.11.036
Abstract:

Proton pump inhibitor( PPI) is often used for the prevention and treatment of digestive system diseases,and the adverse outcomes caused by the use of PPI are increasingly concerned by scholars. This article elaborates on the association of the complications of liver cirrhosis,such as upper gastroint...

Research advances in integrated traditional Chinese and Western medicine therapy for hepatorenal syndrome
SONG JingRu, SUN MingYu
2020, 36(11): 2561-2564. DOI: 10.3969/j.issn.1001-5256.2020.11.037
Abstract:

Hepatorenal syndrome( HRS) is a common complication of severe liver disease,with severe conditions and poor prognosis,and causes a great burden to both patients' family and society. HRS has a complex pathogenesis,and Western medicine treatment has a limited therapeutic effect; therefore,integrated t...

Research advances in non-cirrhotic portal hypertension
LI XiaoKe, XUE ShuWen, YANG XinLe, WANG Tong, JI HuiFan
2020, 36(11): 2565-2568. DOI: 10.3969/j.issn.1001-5256.2020.11.038
Abstract(1069) PDF (234KB)(185)
Abstract:

Portal hypertension is a group of clinical syndromes caused by increased pressure of the portal vein system due to various reasons,with liver cirrhosis as the most common cause,but 10%-20% of portal hypertension cases are secondary to various non-cirrhotic diseases,which are collectively referred to...

Diagnosis and treatment of hepatic vascular tumors
YANG Xu, SUN WenBing, GAO Jun
2020, 36(11): 2569-2573. DOI: 10.3969/j.issn.1001-5256.2020.11.039
Abstract(1276) PDF (268KB)(125)
Abstract:

Hepatic vascular tumors originate from endothelial cells. Except hepatic cavernous angioma,hepatic vascular tumors tend to have a low incidence rate and atypical clinical symptoms and imaging findings,which brings great challenges to clinical diagnosis and treatment.This article reviews the classifi...

Advances in radiofrequency ablation of hepatocellular carcinoma originating from the caudate lobe
LIU JunJie, GU Hao
2020, 36(11): 2574-2578. DOI: 10.3969/j.issn.1001-5256.2020.11.040
Abstract:

Due to its deep anatomic location and complex blood supply characteristics,hepatocellular carcinoma originating from the caudate lobe has become the difficulty in surgical resection,and radiofrequency ablation( RFA) is gradually applied to the treatment of hepatocellular carcinoma originating from t...

Research advances in the serological diagnosis of nonalcoholic fatty liver disease
GUO Tao, HU Bo, YI WeiMin, ZHONG ZhenDong, LIU SuLai, SUN ZengPeng, PENG Chuang
2020, 36(11): 2579-2583. DOI: 10.3969/j.issn.1001-5256.2020.11.041
Abstract:

In recent years,the prevalence rate of nonalcoholic fatty liver disease( NAFLD) has increased significantly and NAFLD has gradually become one of the common chronic liver diseases in China. Patients with NAFLD-related end-stage or deteriorative liver diseases have become one of the main populations ...

Association between hypertension and nonalcoholic fatty liver disease
WANG Xin, HU YiYang, LIU Ping, FENG Qin
2020, 36(11): 2584-2588. DOI: 10.3969/j.issn.1001-5256.2020.11.042
Abstract:

Nonalcoholic fatty liver disease( NAFLD) and hypertension are both important components of metabolic syndrome,and there is a strong association between these two diseases. This article analyzes the association between NAFLD and hypertension based on clinical data and describes the common pathogenese...

Association between anxiety and nonalcoholic fatty liver disease
YU Di, YANG XuYao, ZHAO JinHan, CHUAN LiXue, CHANG Jiang
2020, 36(11): 2589-2592. DOI: 10.3969/j.issn.1001-5256.2020.11.043
Abstract:

With the rapid change in lifestyle in recent years,the prevalence rate of nonalcoholic fatty liver disease( NAFLD) is increasing year by year and it has gradually become one of the major causes of chronic liver diseases. With the development of the bio-psycho-social medical model,the influence of ps...

Influence of drinking on nonalcoholic fatty liver disease
NIU ChunYan, ZHANG Qiang, ZHAO XiangYang
2020, 36(11): 2593-2596. DOI: 10.3969/j.issn.1001-5256.2020.11.044
Abstract:

Nonalcoholic fatty liver disease( NAFLD) is defined as hepatic steatosis without heavy drinking( the amount of alcohol intake is limited within the safe threshold),and the difference between NAFLD and alcoholic liver disease is largely dependent on the amount of alcohol intake. Alcohol intake and NA...

From nonalcoholic fatty liver disease to metabolic fatty liver disease:An analysis based on disease heterogeneity
FENG Gong, YAN QinQin, HE Na, MI Man
2020, 36(11): 2597-2600. DOI: 10.3969/j.issn.1001-5256.2020.11.045
Abstract:

Nonalcoholic fatty liver disease( NAFLD) has become the most important chronic liver disease in the world,but there is still no approved drug for clinical practice. Due to the heterogeneity of NAFLD itself,although drug therapy is being developed,the response rate seems to remain low. In order to me...

Role of liver sinusoidal endothelial cells in the pathogenesis of nonalcoholic fatty liver disease
YANG Jing, GAO Hong, ZHAO YaoWei, WANG Rui
2020, 36(11): 2601-2605. DOI: 10.3969/j.issn.1001-5256.2020.11.046
Abstract:

With the increasing incidence rate of nonalcoholic fatty liver disease( NAFLD) in Western developed countries and rich regions of China year by year,the treatment methods for NAFLD have been constantly improved and NAFLD has become a research hotspot. As an important physiological structure of the l...

Application of bacteriophage technique in the treatment of alcoholic liver disease
MA Huan, TONG Jing, WANG BingYuan
2020, 36(11): 2606-2608. DOI: 10.3969/j.issn.1001-5256.2020.11.047
Abstract:

Alcoholic hepatitis( AH) is a severe alcohol-associated liver disease with a mortality rate as high as 40%. A recent study reveals that the exotoxin( cytolysin)-secreting gut bacterium Enterococcus faecalis is a critical factor for AH,which can be eliminated by bacteriophages,and therefore,the use o...

Application of blood lactate level in evaluating the prognosis of liver failure patients
LI Hui, WANG YongGang, SU HaiBin
2020, 36(11): 2609-2612. DOI: 10.3969/j.issn.1001-5256.2020.11.048
Abstract:

As lactate is elevated due to lactate metabolic disorder in liver failure,recent studies have shown that blood lactate has a high value in predicting the prognosis of liver failure. With reference to the research findings in recent years,this article introduces the prediction model of LiFe score and...

Current status of research on laparoscopic treatment of hepatic cystic echinococcosis
NA BuLaJiang·AiHeMaiTi, TU ErGanAiLi·AJi
2020, 36(11): 2613-2616. DOI: 10.3969/j.issn.1001-5256.2020.11.049
Abstract:

Echinococcosis is a common type of parasitic disease in pastoral areas,and hepatic cystic echinococcosis is mainly observed in clinical practice,with surgical resection as the main treatment method. With the continuous development of endoscopic technology and the advantages of little trauma,clear vi...

Role of bile acids in enterohepatic circulation and mechanism of action of traditional Chinese medicine in regulating bile acids
YE QingLing, WANG MingGang, MAO DeWen, JIANG HaiNan
2020, 36(11): 2617-2620. DOI: 10.3969/j.issn.1001-5256.2020.11.050
Abstract(1084) PDF (239KB)(117)
Abstract:

Bile acids( BAs) are produced in the liver and are the final product of cholesterol catabolism,with a wide range of biological effects. This article reviews the research advances in the synthesis,transport,and metabolism of BAs and the role of BAs in regulating hepatocytes and immunity via enterohep...

Regulatory effect of mTOR pathway-mediated autophagy in liver injury
HUANG Qing, LI JingTao, LIU YongGang, WEI HaiLiang, YAN ShuGuang, GUO YingJun, CHANG ZhanJie
2020, 36(11): 2621-2625. DOI: 10.3969/j.issn.1001-5256.2020.11.051
Abstract:

Autophagy can regulate liver physiology and balance liver metabolism. Autophagy activation has a double-sided and complex effect on liver injury,and it is regulated by many factors and is associated with many protein pathways. This article summarizes the role of m TOR in the regulation of autophagy,...

Application of SpyGlassTM DS Direct Visualization System in the diagnosis and treatment of biliary tract diseases
XU Wen, MIAO Long, WANG ZhengFeng, ZHOU WenCe
2020, 36(11): 2626-2629. DOI: 10.3969/j.issn.1001-5256.2020.11.052
Abstract:

Due to the need of the diagnosis and minimally invasive treatment of biliary tract diseases,peroral choledochoscopy has recently become an important method for the diagnosis and treatment of biliary tract diseases,which helps to avoid some invasive and unnecessary surgical procedures. This article i...

Research advances in insulin resistance in chronic pancreatitis and pancreatic cancer
LI YongKang, YANG NenHong
2020, 36(11): 2630-2632. DOI: 10.3969/j.issn.1001-5256.2020.11.053
Abstract:

Insulin resistance is a manifestation of glucose metabolism disorder secondary to pancreatic disease,and previous studies have shown that it is associated with inflammatory factors and tumor progression. This article reviews the mechanism and influence of insulin resistance in chronic pancreatitis a...